Beyond PFAS: A New Wave of Endocrine Disruptor Litigation

Start
Much of the recent public and legal spotlight has been on per- and polyfluoroalkyl substances (PFAS), the so-called forever chemicals pervasive in consumer products and linked to health risks. But PFAS are not the only chemicals drawing scrutiny. Litigation trends in the chemical arena have increasingly followed the science….
By: Eversheds Sutherland (US) LLP
Previous Story

California Car Accidents Claims: The Discovery Process

Next Story

Cell & gene therapy clinical trials, development promoted in three new FDA guidance documents – Trends in Cell, Tissue, and Gene Therapies